- Home
- TNGX vs CSIQ Comparison
TNGX vs CSIQ Comparison
Compare TNGX & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CSIQ
- Stock Information
- Founded
- TNGX 2014
- CSIQ 2001
- Country
- TNGX United States
- CSIQ Canada
- Employees
- TNGX N/A
- CSIQ N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CSIQ Semiconductors
- Sector
- TNGX Health Care
- CSIQ Technology
- Exchange
- TNGX Nasdaq
- CSIQ Nasdaq
- Market Cap
- TNGX 723.2M
- CSIQ 746.1M
- IPO Year
- TNGX N/A
- CSIQ 2006
- Fundamental
- Price
- TNGX $6.63
- CSIQ $10.87
- Analyst Decision
- TNGX Strong Buy
- CSIQ Hold
- Analyst Count
- TNGX 6
- CSIQ 6
- Target Price
- TNGX $10.00
- CSIQ $11.53
- AVG Volume (30 Days)
- TNGX 1.3M
- CSIQ 2.0M
- Earning Date
- TNGX 11-05-2025
- CSIQ 08-21-2025
- Dividend Yield
- TNGX N/A
- CSIQ N/A
- EPS Growth
- TNGX N/A
- CSIQ N/A
- EPS
- TNGX N/A
- CSIQ N/A
- Revenue
- TNGX $24,296,000.00
- CSIQ $5,919,361,000.00
- Revenue This Year
- TNGX $6.56
- CSIQ $7.77
- Revenue Next Year
- TNGX N/A
- CSIQ $22.71
- P/E Ratio
- TNGX N/A
- CSIQ N/A
- Revenue Growth
- TNGX N/A
- CSIQ N/A
- 52 Week Low
- TNGX $1.03
- CSIQ $6.57
- 52 Week High
- TNGX $10.85
- CSIQ $19.55
- Technical
- Relative Strength Index (RSI)
- TNGX 49.24
- CSIQ 48.14
- Support Level
- TNGX $6.25
- CSIQ $10.56
- Resistance Level
- TNGX $7.40
- CSIQ $11.25
- Average True Range (ATR)
- TNGX 0.40
- CSIQ 0.64
- MACD
- TNGX -0.05
- CSIQ 0.08
- Stochastic Oscillator
- TNGX 33.04
- CSIQ 60.83
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.